Procter & Gamble Downgraded to “Market Perform” at BMO Capital (PG)
Consumer products maker The Procter & Gamble Company ( PG ) on Monday caught a downgrade from analysts at BMO Capital. The firm said it cut its rating on PG...
Comcast Now Rated a “Buy” at Goldman Sachs (CMCSA)
Cable TV and Internet provider Comcast Corporation ( CMCSA ) on Monday saw its coverage restarted with a “Buy” rating by analysts at Goldman Sachs....
Dividend.com Sunday Edition – Suze Orman Helps Beat the Dividend Drum
Investors will certainly be bracing for another week of ups and downs as the Middle East tensions continue to impact oil prices, which is already being passed on...
Bet on Transformational Technologies to Trump Political Ideology
Emerging transformational technologies, as economist Joseph Schumpeter pointed out, do not advance the economy by consistent predictable increments. Rather, they...
Newmont Mining Q4 Profit Rises, Beating View (NEM)
Gold producer Newmont Mining Corporation ( NEM ) on Thursday said its fourth quarter profit surged 46% from last year on higher gold selling prices, beating analyst...
Marathon Oil’s Target, Estimates Boosted at Morgan Stanley (MRO)
Integrated oil and natural gas company Marathon Oil Corporation ( MRO ) on Wednesday saw its price target and earnings estimates raised by analysts at Morgan Stanley....
My Last Coal Reco is up 823%
You won’t find it in the mainstream press, but coal is undergoing a massive boom. China is the biggest burner of coal on earth, accounting for 50% of all...
The Miracle of Regenerative Medicine
Tall, dark, and handsome… Dr. Anthony Atala is not a guy you could easily mistake for Dr. Frankenstein. Yet, in his white lab coat, Atala is doing exactly...
Inflation in (Mostly) the Wrong Places
It is often claimed that inflation is a benign, even positive, force. People assume that prices, wages, and assets will all rise together… In the real world,...
Marathon Oil’s Target Boosted at Goldman Sachs (MRO)
Integrated oil and natural gas producer Marathon Oil Corporation ( MRO ) on Monday saw its price target upped by analysts at Goldman Sachs. The firm said it raised...
Weekend: The Fool Proof Retirement Plan
Welcome to the Wealth Daily Weekend Edition— our insights from the week in investing and links to our most-read Wealth Daily and sister publication articles....
All That Jazz (JAZZ): Biotech Targets Narcolepsy, OCD and Anxiety
Filed under: Newsletters , Stocks to Buy “The visible growth story at Jazz Pharmaceuticals ( JAZZ ) is the narcolepsy treatment Xyrem, which accounts for...

